The Russian pharmaceutical company "Geropharm" has created and registered insulin "Ringluzin". This was reported in the company's press service.
The new drug is the first Russian analogue of the French insulin "Apidra".
"Geropharm" registered a new insulin "Ringluzin" with the active substance glulisine, which is equal in strength to ordinary human insulin.
"Ringluzin" will be produced from the substance to the finished drug according to the principle of a full cycle at the Geropharm plants in the Moscow region and St. Petersburg. The volume of production will be determined based on demand.
Earlier www1.ru reported that new antibiotics will appear in Russia.
Read materials on the topic:
Stavropol scientists have developed nanoparticles to increase the effectiveness of antibiotics
First in the world: a gel for bone regeneration after gunshot wounds was invented in Russia
Russia has developed drugs for spinal muscular atrophy and Bekhterev's disease
Now on home
Герой России Гарнаев: никто из профессионалов о возобновлении производства на КАЗ всерьёз не говорит
Система отслеживает спутники на высотах до 50 000 км и ведёт за ними наблюдение
The armored vehicle is equipped with a KamAZ-740.35-400 diesel engine with a power of 400 hp.
Constant improvements in avionics, weapons and tactical capabilities will make the aircraft a flexible response to future challenges
The exterior of the KamAZ-54901 features fairings on the cab and chassis for fuel economy
Fighters are in demand both domestically and abroad
Tyazhpromexport and Venezuela Agree on Plant Revival
The company not only completed the state order, but also quickly mastered the production of AK-12K for special forces
Experts have developed a photogrammetric complex with a resolution of less than 1 cm
